Cardium noncompliant with listing terms

Cardium Therapeutics (San Diego) reported notification from the staff of its current listing exchange indicating that the company is currently considered to be noncompliant with certain listing requirements of the NYSE Alternext US LLC (formerly the American Stock Exchange). Based on the company's quarterly report on Form 10-Q, which was filed on Nov. 10, 2008, noncompliance was noted with respect to the requirements for minimum stockholders' equity and maintenance of a sufficient base of financial resources to support expected activities, under sections 1003(a)(i) and (iv), respectively, of the exchange's current company guide.

Cardium Therapeutics, and its subsidiaries, InnerCool Therapies and the Tissue Repair Company, are primarily focused on therapeutic products and devices for cardiovascular, ischemic and related indications.